International Immunology Advance Access originally published online on June 20, 2005
International Immunology 2005 17(7):921-930; doi:10.1093/intimm/dxh272
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TGF-ß signaling of human T cells is modulated by the ancillary TGF-ß receptor endoglin
1 Swiss Institute of Allergy and Asthma Research (SIAF), Obere Strasse 22, CH-7270 Davos, Switzerland
2 Hospital for Sick Children and Department of Immunology, University of Toronto, 555 University Avenue, Toronto M5G1X8, Canada
3 Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro de Maeztu 9, 28040 Madrid, Spain
Correspondence to: C. B. Schmidt-Weber; E-mail: csweber{at}siaf.unizh.ch
Transforming growth factor beta (TGF-ß) inhibits T cell activation and alters differentiation of naive T cells into effector cells. Although four main cell-surface proteins can interact with TGF-ß, only the signaling receptors type I (TGF-ßR type I) and type II (TGF-ßR type II) have so far been described on T cells. The aim of the present study was to investigate the expression of the ancillary receptor endoglin (CD105) by T cells and its role in TGF-ß-mediated signal transduction and function. CD105 expression was analyzed on resting and activated human CD4+ T cells by flow cytometry, western blot, immunoprecipitation, proliferation and SMAD-responsive reporter gene assays. CD4+ T cells constitutively expressed CD105 in memory T cells and partially also in naive T cells; however, surface expression is regulated and is increased following TCR engagement, which induced serine/threonine phosphorylation of CD105. In contrast to the suppressive signal mediated by the TGF-ß, cross-linking of CD105 substantially enhanced T cell proliferation, indicating that CD105 by itself mediates signal transduction. Furthermore, CD105 cross-linking induced SMAD-independent signaling via ERK kinase phosphorylation. The present study demonstrates that CD105 is expressed on the surface by activated CD4+ T cells and CD3 regulated by post-translational means. Furthermore, CD105 acts as a regulatory receptor, counteracting TGF-ß-mediated suppression.
Keywords: cytokine receptor, T lymphocytes, tolerance/suppression/anergy
Transmitting editor: S. Kaufmann
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. L. Moody, S. Singbrant, G. Karlsson, U. Blank, M. Aspling, J. Flygare, D. Bryder, and S. Karlsson Endoglin Is Not Critical for Hematopoietic Stem Cell Engraftment and Reconstitution but Regulates Adult Erythroid Development Stem Cells, November 1, 2007; 25(11): 2809 - 2819. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Meng, A. Lux, A. Holloschi, J. Li, J. M. X. Hughes, T. Foerg, J. E. G. McCarthy, A. M. Heagerty, P. Kioschis, M. Hafner, et al. Identification of Tctex2beta, a Novel Dynein Light Chain Family Member That Interacts with Different Transforming Growth Factor-beta Receptors J. Biol. Chem., December 1, 2006; 281(48): 37069 - 37080. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Koleva, B. A. Conley, D. Romero, K. S. Riley, J. A. Marto, A. Lux, and C. P. H. Vary Endoglin Structure and Function: DETERMINANTS OF ENDOGLIN PHOSPHORYLATION BY TRANSFORMING GROWTH FACTOR-beta RECEPTORS J. Biol. Chem., September 1, 2006; 281(35): 25110 - 25123. [Abstract] [Full Text] [PDF] |
||||

